Total Funding
70
18
Total FundingSeries A raised
Growth Score
-17 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
273256
Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.
- Larry Green: CEOPast Role: AlivaMab Biologics, Founder & Chairman Of The Board
Hiroaki Shizuya: Founder
About the Company
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, was founded in December 2009, based on technology principles established by its subsidiary, Aliva Biopharmaceuticals, Inc.
